Home > Insider Trading > Filing (0001290677-23-000039)

Filing Details

Accession Number:: 0001290677-23-000039
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-15 21:21:30
Reporting Period:: 2023-05-15

Accepted Time:: 2023-05-15 21:21:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1290677	Turning Point Brands Inc.	TPB	Tobacco Products (2100)	133961898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1794878	Graham Purdy	5201 Interchange Way Louisville KY 40229	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-15	1,000	$20.78	174,812	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Options (2022)	$30.46	2032-03-14	12,000	12,000	Direct
Common Stock	Options (2021)	$51.75	2031-02-18	9,000	9,000	Direct
Common Stock	Options (2020)	$14.85	2030-03-18	11,000	11,000	Direct
Common Stock	Options (2019)	$47.58	2029-03-20	5,500	5,500	Direct
Common Stock	Options (2018)	$21.21	2028-03-07	8,900	8,900	Direct
Common Stock	Options (2017)	$15.41	2027-05-17	5,000	5,000	Direct
Common Stock	Options (2014)	$3.83	2024-08-08	5,216	5,216	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2032-03-14	12,000	12,000	Direct
2031-02-18	9,000	9,000	Direct
2030-03-18	11,000	11,000	Direct
2029-03-20	5,500	5,500	Direct
2028-03-07	8,900	8,900	Direct
2027-05-17	5,000	5,000	Direct
2024-08-08	5,216	5,216	Direct

Footnotes

Granted pursuant to the issuer's 2006 Equity Plan
Granted pursuant to the issuer's 2021 Equity Incentive Plan.
The options vested and became exercisable as to 50% of the underlying shares on August 8, 2014, 25% of the underlying shares on August 8, 2015 and 25% of the underlying shares on August 8, 2016.
Granted pursuant to the issuer's 2015 Equity Incentive Plan.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022, and 33% of the underlying shares on January 1, 2023.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023, and 33% of the underlying shares on January 1, 2024.
The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024, and 33% of the underlying shares on January 1, 2025.
The total reported in Column 5 includes 29,466 restricted stock units and 145,346 shares of common stock.
Weighted average sale price. On 05/15/2023, the reporting person purchased the shares within a range of $20.74 to $20.79. The reporting person will provide upon request by the Commission Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price